[ET Net News Agency, 27 January 2022] INNOVENT BIO (01801) fell 7.84% to HK$34.1.
It hits an intra-day low of HK$34.1, hitting a 52-week low, and an intra-day high of
HK$35.9. The total shares traded was 347,000, with a value of HK$12.15m. The active
buy/sell ratio is 51:49, with net buying turnover of HK$83,925. FUTU SEC INT'L accounts
for greatest net responsive buying turnover of HK$1.19m, with volume weighted average
price of HK$35.168. MORGAN STANLEY HK SEC accounts for greatest net responsive selling
turnover of HK$1.52m, with volume weighted average price of HK$34.855. The stock has
fallen a combined 20.7% over the past 5 consecutive trading days.
The Hang Seng Index now fell 452 points, or 1.86% to 23,837; the Hang Seng China
Enterprises Index now fell 188 points, or 2.22% to 8,323; the Hang Seng TECH Index now
fell 165 points, or 2.96% to 5,431; with an overall turnover of HK$6.01b.
The SSE Composite Index now fell 8 points, or 0.25% to 3,447, with an overall turnover
of RMB10.53b.
The SZSE Component Index now fell 49 points, or 0.36% to 13,730, with an overall
turnover of RMB5.62b.
Basic Information
=================
----------------------------------
Nominal 34.100 % Chg -7.84%
High 35.900 Low 34.100
Shares Tr 347,000 Turnover 12.15m
10-D SMA 40.605 %H.V 75.662
20-D SMA 41.742 VWAP 35.024
50-D SMA 54.461 RSI14 26.791
----------------------------------
Status: Hitting a 52-week low, active buy/sell ratio is 51:49, with net buying turnover of
HK$83,925, falling a combined 20.7% over the past 5 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
INNOVENT BIO (01801) 34.10 -7.84
GENSCRIPT BIO (01548) 23.50 -9.62
VIVA BIOTECH (01873) 4.00 -0.99
JUNSHI BIO (01877) 46.80 -1.99
JXR (01951) 7.92 -0.25
BRII-B (02137) 17.80 -0.67
WUXI BIO (02269) 77.45 -2.82
TIGERMED (03347) 84.40 -1.52
CANSINOBIO-B (06185) 137.00 +1.93
AKESO-B (09926) 22.25 -4.30
---------------------------------------------
(ed)